Long-term fear of cancer recurrence in patients treated endoscopically for early Barrett’s neoplasia
Diseases of the Esophagus · 2023
DOI: 10.1093/dote/doac083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diseases of the Esophagus, 2023. Verfasst von Wilda D Rosmolen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Barrett Esophagus, Esophageal Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Previous studies on fear of cancer recurrence after endoscopic treatment for early Barrett’s neoplasia focused on fear during a relatively short period after the intervention. The aim of this study was to explore whether fear of cancer (recurrence) persists during long-term follow-up in patients treated endoscopically for Barrett’s neoplasia compared to patients treated surgically for a more advanced stage of esophageal adenocarcinoma. Participants previously participated in a prospective longitudinal study investigating quality of life and fear of cancer recurrence and were treated endoscopically for early Barrett’s neoplasia (high-grade dysplasia—T1sm1N0M0) or surgically for a more advanced esophageal adenocarcinoma (T1N0M0–T3N1M0). For the present study, participants were again invited to complete a set of questionnaires including the fear of cancer recurrence scale (FORS), worry for cancer scale (WOCS), and the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS Anxiety). Thirty-nine patients were eligible in the endoscopy group and 28 in the surgical group. The median time between the baseline measurement (original study) and the long-term follow-up assessment was 4 years (interquartile range 3–5 years). Fear and worry for cancer recurrence and general anxiety diminished over time in both treatment groups. However, at long-term follow-up, endoscopically treated patients had significantly higher levels of worry for cancer and general anxiety than surgically treated patients. Fear of cancer recurrence did not significantly differ between endoscopically and surgically treated patients. We found that worry and fear of cancer recurrence and general anxiety in endoscopically treated patients declined over time, but not as much as in surgically treated patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
- Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
- Department of Medical Psychology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Zitieren
APA
Rosmolen, W. D., Pouw, R. E., van Berge Henegouwen, M. I., Bergman, J. J., Sprangers, M. A., & Nieuwkerk, P. T. (2023). Long-term fear of cancer recurrence in patients treated endoscopically for early Barrett’s neoplasia. Diseases of the Esophagus. https://doi.org/10.1093/dote/doac083
Vancouver
Rosmolen WD, Pouw RE, van Berge Henegouwen MI, Bergman JJ, Sprangers MA, Nieuwkerk PT. Long-term fear of cancer recurrence in patients treated endoscopically for early Barrett’s neoplasia. Diseases of the Esophagus. 2023. doi:10.1093/dote/doac083
BibTeX
@article{Rosmolen2023,
author = {Rosmolen, Wilda D and Pouw, Roos E and van Berge Henegouwen, Mark I and Bergman, Jacques J and Sprangers, Mirjam A and Nieuwkerk, Pythia T},
title = {Long-term fear of cancer recurrence in patients treated endoscopically for early Barrett’s neoplasia},
journal = {Diseases of the Esophagus},
year = {2023},
doi = {10.1093/dote/doac083}
}
EUVIMED